Treatment with the soluble guanylate cyclase activator BAY 60–2770 normalizes bladder function in an in vivo rat model of chronic prostatitis

Prostate‐to‐bladder cross‐sensitization in a model of zymosan‐induced chronic pelvic pain syndrome in rats

(2021) Ozgu Aydogdu et al.   PROSTATE

Cross-organ sensitization between the prostate and bladder in an experimental rat model of lipopolysaccharide (LPS)-induced chronic pelvic pain syndrome

(2021) Ozgu Aydogdu et al.   BMC Urology

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review

(2020) Juan V.A. Franco et al.   BJU INTERNATIONAL

Bladder overactivity and afferent hyperexcitability induced by prostate-to-bladder cross-sensitization in rats with prostatic inflammation

(2019) Yasuhito Funahashi et al.   JOURNAL OF PHYSIOLOGY-LONDON

Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia

(2019) Ippei Hiramatsu et al.   INTERNATIONAL JOURNAL OF UROLOGY

Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress

(2018) Awais Ullah Ihsan et al.   BIOMEDICINE & PHARMACOTHERAPY

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

(2018) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia

(2018) So Inamura et al.   PROSTATE

Effect of tadalafil on chronic pelvic pain and prostatic inflammation in a rat model of experimental autoimmune prostatitis

(2018) Ken Okamoto et al.   PROSTATE

Stimulators and activators of soluble guanylate cyclase for urogenital disorders

(2017) Fabiola Z. Mónica et al.   Nature Reviews Urology

Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue

(2017) Venkata K. Yellepeddi et al.   PROSTATE

Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome

(2016) Giuseppe Magistro et al.   EUROPEAN UROLOGY

Chronic Prostatitis Induces Bladder Hypersensitivity and Sensitizes Bladder Afferents in the Mouse

(2016) Erica S. Schwartz et al.   JOURNAL OF UROLOGY

Soluble Guanylate Cyclase Modulators, BAY 41-2272 and BAY 60-2770, Inhibit Human and Rabbit Prostate Contractility

(2016) Fabiano B. Calmasini et al.   UROLOGY

Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model

(2016) Y. Hu et al.   Andrology

Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor

(2014) C. Füllhase et al.   NEUROUROLOGY AND URODYNAMICS

Signalling Molecules in the Urothelium

(2014) Michael Winder et al.   Biomed Research International

The sGC activator BAY 60-2770 has potent erectile activity in the rat

(2013) George F. Lasker et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The Soluble Guanylyl Cyclase Activator BAY 60-2770 Ameliorates Overactive Bladder in Obese Mice

(2013) Luiz O. Leiria et al.   JOURNAL OF UROLOGY

Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats

(2013) L.-W. Fan et al.   NEUROSCIENCE

Purinergic signalling in the urinary tract in health and disease

(2013) Geoffrey Burnstock   Purinergic Signalling

Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial

(2012) Matthias Oelke et al.   EUROPEAN UROLOGY

Nitric Oxide Signaling Pathways Involved in the Inhibition of Spontaneous Activity in the Guinea Pig Prostate

(2012) Anupa Dey et al.   JOURNAL OF UROLOGY

The Prevalence and Overlap of Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Men: Results of the RAND Interstitial Cystitis Epidemiology Male Study

(2012) Anne M. Suskind et al.   JOURNAL OF UROLOGY

Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60–2770, are not dependent on endogenous nitric oxide or reduced heme

(2011) Edward A. Pankey et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

(2011) Mauro Gacci et al.   EUROPEAN UROLOGY

Pharmacological modulation of the micturition pattern in normal and cyclophosphamide pre-treated conscious rats

(2010) M. Andersson et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA)

(2009) W.P. Zhao et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces β3-adrenoceptor-mediated relaxation, causing rat detrusor overactivity

(2008) F Z T Mónica et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat

(2008) M C Andersson et al.   BRITISH JOURNAL OF PHARMACOLOGY

Epidemiology of prostatitis

(2008) John N. Krieger et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms

(2008) George T. Kedia et al.   WORLD JOURNAL OF UROLOGY